New non-invasive treatments for the control and treatment of early childhood caries
| ISRCTN | ISRCTN17005348 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN17005348 |
| EudraCT/CTIS number | 2021-003400-41 |
| Secondary identifying numbers | BZ01A1 |
- Submission date
- 16/06/2021
- Registration date
- 30/06/2021
- Last edited
- 08/04/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
Oral health is essential to general health and significantly influences the development of children. Dental caries (tooth decay) has a high economic and social impact due both to the treatment costs as well as the days lost in school by children and at work by their parents, and the effects that remain throughout life. Also, as caries are associated with high sugar intake, they are a predictor of risk for heart disease and diabetes in children and adults. The causes of early childhood caries are complex and the main associated factors are high sugar consumption and inadequate oral hygiene. The traditional operative treatment of cavities often fails, especially when tooth restoration is performed at an early age. Less invasive caries treatment strategies have been proposed that would have the advantage of lowering the costs of care as well as decreasing the number of tooth extractions. Fluoride applications are effective at decreasing the incidence of early childhood caries while silver diamine fluoride (SDF) is effective at arresting the progression of cavities. However, a usual adverse effect of SDF is that it stains the teeth black. New formulations have appeared that replace silver with copper (Tiefenfluorid) to avoid this. At this moment, the effectiveness of Tiefenfluorid in permanent teeth is proven, but there are no studies in deciduous dentition (milk teeth), or clinical studies comparing the effectiveness of these non-invasive treatments. Also, there is a gap in knowledge about which treatments are most effective and how the interval between applications influences clinical effectiveness. To date, it is known that a biannual application is better than one application per year, but other application schedules have not been studied. This study could provide important information on the effectiveness, cost-effectiveness and potential side-effects of these methods for patients. The main of the study is to find out which high-concentration fluoride application method and schedule is more effective at preventing complications arising from early childhood caries in preschool children.
Who can participate?
Children aged 1-6 years with severe early childhood caries
What does the study involve?
Participants are randomly allocated into six groups - three treatment methods (silver diamine fluoride [SDF], fluoride solution with copper ions (Tiefenfluorid) and placebo [without any active substance, but ensuring nonrestorative caries control]), applied at two different intervals: 1) semiannual and 2) four times weekly. Parents (direct caregivers) will be advised about tooth cleaning and diet and are recommended to brush their teeth with toothpaste that contains fluoride. The researchers will record general information about the child, hygiene and dietary habits, plaque, and caries damage and activity at the beginning of the study and 12 months later. The researchers will measure pain and inflammation history, the number of extracted and restored teeth during the observation period (12 months), the change of the activity of the carious lesions, the parents’ and children’ satisfaction with the treatment and with the way teeth look, the direct costs of the treatment and any undesirable side effects.
What are the possible benefits and risks of participating?
All participants will receive an immediate benefit - individualized recommendations, which will be given using motivational interviewing principles, assuring that everybody has the chance to change their behaviour and avoid cavities in the future. One-third of participants will receive up to date the most effective non-restorative cavity control method with silver diamine fluoride, the others will benefit from toothbrushing with fluoride and other interventions, including Tiefenfluoride, the effectiveness of which is not clear at the moment. All participants will have access to immediate care in case of progression and complications, including attention in general anaesthesia for free. There are no registered allergic reactions to the used materials, but the researchers will avoid including children who have experienced several allergic reactions. They will also never use an amount close to the maximum dose of the products to avoid any health effects.
Where is the study run from?
Riga Stradins University (Latvia)
When is the study starting and how long is it expected to run for?
March 2020 to February 2023
Who is funding the study?
1. Riga Stradins University (Latvia)
2. European Regional Development Fund (European Union)
Who is the main contact?
Ilze Maldupa
ilze.maldupa@rsu.lv
Contact information
Scientific
Dzirciema Street 20
Riga
LV-1007
Latvia
 ORCID ID |
0000-0002-5967-956X |
|---|---|
| Phone | +371 (0)26394304 |
| ilze.maldupa@rsu.lv |
Study information
| Study design | Randomized triple-blinded placebo-controlled single-centre clinical trial with six parallel groups |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised parallel trial |
| Study setting(s) | University/medical school/dental school |
| Study type | Treatment, Efficacy |
| Participant information sheet | Not available in web format, please use the contact details to request a participant information sheet |
| Scientific title | Treatment of early childhood caries with three different topical fluoride treatments: a randomised clinical trial |
| Study acronym | NoCaries |
| Study objectives | Application of topical fluoride treatment methods will lower the complication rate of early childhood caries from 30% to 10% in preschool children. |
| Ethics approval(s) |
1. Approved 28/05/2020, Riga Stradins University Research Ethics Committee (Dzirciema Street 16, Riga, LV-1007, Latvia; +371 (0)67061596; pek@rsu.lv), ref: Nr.6-1/06/20 2. Approved 23/12/2022, Amendment approved by Riga Stradins University Research Ethics Committee (Dzirciema Street 16, Riga, LV-1007, Latvia; +371 (0)67061596; pek@rsu.lv), ref: 2-PĒK-4/627/2022 |
| Health condition(s) or problem(s) studied | Early childhood caries |
| Intervention | Patients are allocated into groups using restricted randomization - there are pre-numbered six colour cards; patients are allocated to the group which corresponds to the number of the next card after signing informed consent. The first placebo group: placebo application twice with a 6-month interval and a recommendation to brush teeth with a toothpaste containing fluoride (F content of at least 1000 ppm) The second placebo group: placebo application four times with a week’s interval and a recommendation to brush teeth with a toothpaste containing fluoride (F content of at least 1000 ppm) The first SDF group: Riva Star SDF (35-40% silver fluoride, 15-20% ammonium) application twice with a 6-month interval and a recommendation to brush teeth with a toothpaste containing fluoride (F content of at least 1000 ppm) The second SDF group: Riva Star SDF application four times with a week’s interval and a recommendation to brush teeth with a toothpaste containing fluoride (F content of at least 1000 ppm) The first Tiefenfluorid group: Tiefenfluorid (0.4% CuSiF₆ x 6 H₂O, 10.9% MgSiF₆ x 6 H₂O, 0,1% NaF, 9.6% Ca(OH)₂) application twice with a 6-month interval and a recommendation to brush teeth with a toothpaste containing fluoride (F content of at least 1000 ppm) The second Tiefenfluorid group: Tiefenfluorid application four times with a week’s interval and a recommendation to brush teeth with a toothpaste containing fluoride (F content of at least 1000 ppm) For ethical reasons, a negative control group will not be used – in each of the study’s groups, the parents (direct caregivers) will be given advice about tooth cleaning and diet, observing motivational intervention principles and recommending brushing teeth with toothpaste that contains fluoride, which is defined as non-restorative caries treatment and which has also proven its effectiveness in stopping caries damage. |
| Intervention type | Behavioural |
| Primary outcome measure | 1. Pain history during the observation period, assessed as Yes/No by two calibrated dentists at the 12 months follow-up visit 2. Abscess history during the observation period, assessed as Yes/No by two calibrated dentists at the 12 months follow-up visit 3. The number of newly extracted or otherwise surgically treated teeth during the observation period, assessed using medical records at the 12 months follow-up visit |
| Secondary outcome measures | 1. The change in the overall activity of caries as Active/Non-active, assessed by two calibrated dentists at the 12 months follow-up visit 2. The progression and change of activity of every lesion, assessed by International Caries Detection and Assessment System (ICDAS) (progression) and Nyvad (activity) criteria, at the 12 months follow-up visit 3. The parent’s satisfaction with the way their children’s teeth look, assessed by a questionnaire asking: “Are you satisfied with the way your child’s teeth look?” and “Would you agree to repeat the treatment procedure used?” on a 5-point Likert scale, at the 12 months follow-up visit 4. The child’s satisfaction with their teeth, measured by the visual analogue scale (VAS) with three points (happy, not sure, sad) at the 12 months follow-up visit 5. The child’s feelings during the treatment, measured by the modified Wong-Baker scale with three options (no hurt, hurts a little, hurts a lot), during every appointment (depending on treatment group can be assessed at baseline, 1, 2, 3 weeks and 12 months; or at baseline, 6 and 12 months) 6. The direct costs of the treatment and the cost-effectiveness, calculated as EUR spent per treatment protocol; EUR per prevented major complications (patient-level - pain, abscess, extraction) and EUR per prevented minor complications (tooth-level - progression of caries lesion), calculated at the 12 months follow-up visit 7. The treatment method’s undesirable side effects, assessed by parent questionnaire at the 12 months follow-up visit |
| Overall study start date | 01/03/2020 |
| Completion date | 28/02/2023 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Lower age limit | 1 Year |
| Upper age limit | 6 Years |
| Sex | Both |
| Target number of participants | 420 |
| Total final enrolment | 420 |
| Key inclusion criteria | 1. Children aged 1-6 years 2. Have at least one active caries damage with cavitates (comply with the diagnosis of severe early childhood caries [S-EEC]) 3. Wish to participate in the study 4. Parents agree to participate in the study and sign a consent form |
| Key exclusion criteria | 1. The child arrives with an adult who doesn’t have the right to sign a consent form, and the person responsible for the child cannot be present 2. Chronic or serious acute general illness 3. In the last month has used medications that could affect the secretion of saliva 4. Previously received treatment with products that have a high level of fluoride concentration |
| Date of first enrolment | 01/09/2020 |
| Date of final enrolment | 31/05/2021 |
Locations
Countries of recruitment
- Latvia
Study participating centre
Dzirciema Street 20
Riga
LV-1007
Latvia
Sponsor information
University/education
Dzirciema Street 20
Riga
LV-1007
Latvia
| Phone | +371 (0)67409261 |
|---|---|
| rsu@rsu.lv | |
| Website | http://www.rsu.lv/eng/ |
"ROR" |
https://ror.org/03nadks56 |
Funders
Funder type
University/education
Government organisation / Universities (academic only)
- Alternative name(s)
- Rīga Stradiņš University, Rīga Stradiņš University, Universitas Rigensis Stradina, Riga Medical Institute, Medical Academy of Latvia, RSU
- Location
- Latvia
Government organisation / National government
- Alternative name(s)
- Europski Fond za Regionalni Razvoj, Den Europæiske Fond for Regionaludvikling, Europees Fonds voor Regionale Ontwikkeling, Euroopa Regionaalarengu Fond, Fonds Européen de Développement Régional, Europäischer Fonds für regionale Entwicklung, Európai Regionális Fejlesztési Alap, Fondo Europeo di Sviluppo Regionale, Eiropas Reģionālās attīstības fonds, Europos Regionines Pletros Fondas, Europejski Fundusz Rozwoju Regionalnego, Fundo Europeu de Desenvolvimento Regional, Fondul European de Dezvoltare Regională, Európsky Fond Regionálneho Rozvoja, Fondo Europeo de Desarrollo Regional, Европейски фонд за регионално развитие, Evropský fond pro regionální rozvoj, Ευρωπαϊκό Ταμείο Περιφερειακής Ανάπτυξης, Il-Fond Ewropew għall-Iżvilupp Reġjonali, Evropski sklad za regionalni razvoj, Euroopan aluekehitysrahasto, Europeiska regionala utvecklingsfonden, ERDF, FEDER, EFRE, ЕФРР, EFRR, EFRU, ERFi, ΕΤΠΑ, FEDER, FESR, ERAF, ERPF, ERFA, L-FEŻR, EFRO, EFRR, FEDR, ESRR, EAKR, Eruf
Results and Publications
| Intention to publish date | 28/02/2024 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Stored in repository |
| Publication and dissemination plan | Current publication and dissemination plan as of 24/10/2023: The publication "Clinical effectiveness/child-patient and parent satisfaction of two topical fluoride treatments for caries: a randomised clinical trial" has been submitted to Scientific Reports. Previous publication and dissemination plan: The protocol, data management plan and an anonymised and de-identified version of the data (full or partial) and the statistical analysis script will be published in the institutional repository of the Riga Stradiņš University (RSU). The protocol will be published in PDF format, the data in CSV format and the statistical analysis script in R Markdown format. D6.3 Publication about the effectiveness of SDF and Tiefenfluorid treatment in preschool children with S-ECC (to be published in Caries Research (impact factor: 2.188) or in BMC Oral Health (impact factor: 1.602). D6.4 Publication about the effectiveness of fluoride treatment according to the type of carious lesion in deciduous dentition (to be published in the International Journal of Paediatric Dentistry (impact factor: 2.18) or in European archives of paediatric dentistry: official journal of the European Academy of Paediatric Dentistry (impact factor: 1.48). |
| IPD sharing plan | Current IPD sharing plan as of 24/10/2023: The datasets generated and analysed during the current study are available in the Zenodo repository: https://zenodo.org/record/7677435. Previous IPD sharing plan: The original data, along with the codebook and analysis scripts, will be published in the RSU institutional data repository at https://dataverse.rsu.lv/. The data will consist of csv sheets with the data of the patients and R analysis scripts. The dataset will be called dataset and the dataset generated by the research, including also preprints and technical reports, will be called dataverse. The dataverse corresponding to this investigation will receive a digital object identifier (DOI). The citation has seven components. Five are human-readable: the author(s), title, year, data repository (or distributor), and version number. Two components are machine-readable: the DOI and the universal numeric fingerprint (UNF). The data generated will be de-identified using R's randomizeR package, removing all personal information. The naming convention for the archives will be date in yyyymmdd-version-identifier.extension format. The use of spaces will be avoided, being replaced by -. The WHO classification will be used, so the metadata associated with this classification, available at https://www.who.int/publications/data/gho/indicator-metadata-registry/imr-details/3812, will be used. The original anonymized data will be published with restricted access once the data cleaning and exploratory analysis stage is completed. The data will be made public at the time of sending the final report to a peer-reviewed journal, with its DOI corresponding to the data associated with the research. The data will be embargoed until the final report is accepted, at which time it will become publicly available. No access restrictions will be applied to the data once the final project report has been accepted. The formats to be used will be csv for spreadsheet data, R Markdown for analysis scripts, pdf and csv for codebooks and odt or txt for text files. If any other format is used, the alternative open version will be used. The versions of the programs used for data analysis will be included. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol file | 08/07/2021 | No | No | ||
| Protocol file | version 2.0 | 25/08/2021 | 27/02/2023 | No | No |
| Dataset | Data and the research script | 25/02/2023 | 24/10/2023 | No | No |
| Results article | 07/04/2024 | 08/04/2024 | Yes | No |
Additional files
- ISRCTN17005348_PROTOCOL.pdf
- Uploaded 08/07/2021
- ISRCTN17005348_protocol_v2.0 25.08.2021.pdf
Editorial Notes
08/04/2024: Publication reference added.
24/10/2023: The following changes have been made:
1. Ethics approval for protocol amendment added.
2. Efficacy was added as a study type(s) treatment.
3. Study setting(s) other was replaced with university/medical school/dental school.
4. The publication and dissemination plan was changed.
5. The Individual participant data (IPD) sharing plan was changed.
6. The intention to publish date was changed from 28/10/2023 to 28/02/2024.
7. Dataset link added.
27/02/2023: Uploaded protocol v2.0 (not peer-reviewed) as an additional file.
08/07/2021: Uploaded protocol (not peer reviewed).
30/06/2021: Trial's existence confirmed by the Riga Stradins University Research Ethics Committee.
